MicroRNA与乳腺癌侵袭转移的关系
被引量:5
摘要
文献报道显示乳腺原位癌与侵袭癌相关microRNA种类既有相同者,也有相异者。乳腺癌相关microRNA对癌变和(或)转移的调控能力有的兼具二者,有的仅具其一。microRNA对乳腺癌侵袭、转移的作用包括调控癌细胞迁徙、侵袭与生存能力,改变微环境与促进血管生成及启动瘤细胞上皮——间质转变。乳腺癌干细胞在microRNA调控下不仅促进乳腺癌发生,也与癌侵袭转移的发生、发展密切相关。
出处
《临床与实验病理学杂志》
CAS
CSCD
北大核心
2012年第7期713-716,共4页
Chinese Journal of Clinical and Experimental Pathology
参考文献25
-
1Hurst D R, Edmonds M D, Welch D R. Metastamir: the field of metastasis-regulatory microRNA is spreading [ J ]. Cancer Res, 2009,69 ( 19 ) :7495 - 8.
-
2Hannafon B N, Sebastiani P, de Las Morenas A, et al. Expres- sion of microRNA and their genetarget are dysregulated in preinva- sire breast cancer[ J ]. Breast Cancer Res,2011,13 (2) : R24.
-
3Sempere L F, Christensen M, Silahtaroglu A, et al. Altered mi- croRNA expression confined to specific epithelial cell subpopula- tions in breast cancer [ J ]. Cancer Res, 2007,67 ( 24 ) : 11612 - 20.
-
4Qi L, Bart J, Tan L P, et al. Expression of miR-21 and its targets (PTN, PDCIM, TM1 ) in fiat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma [ J ]. BMC Cancer,2009,9:163.
-
5Tavazoie S F, Alareon C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis [J]. Nature, 2008,451 (7175) : 147 - 52.
-
6Baffa R, Fassan M, Volinia S, et al. microRNA expression profi- ling of human metastatic cancers identifies cancer gene targets [ J ]. J Pathol,2009,219(2) :214 -21.
-
7Shi M, Liu D, Duan H, et al. Metastasis-related miRNAs, active players in breast cancer invasion and metastasis[ J]. Cancer Me- tastasis Rev,2010,29(4) :785 -99.
-
8Greene S B, herschkowitz J I, Rosen J M. Small players with big roles: MicroRNAs as targets to inhibit breast cancer progression [J]. Current Drug Targers,2010,11(9) :1 - 15.
-
9Corcoran C, Friel A M, Duffy M J, et al. In|racellular and extra- cellular microRNAs in breast cancer [ J ]. Clin Chem, 2011,57 (1) :18 -32.
-
10Le X F, Merchant O, Bast R C, Calin G A. The roles of microR- NAs in the cancer invasion-metastasis cascade[ J]. Cancer Micro- environ,2010,3 ( 1 ) :137 -47.
二级参考文献29
-
1Molyneux G, Regan J, Smalley M J.Mammary stem cells and breast cancer[J]. Cell Mol Life Sci ,2007. 1 -13.
-
2Sims AH, Howell A, Howell S J,Clarke R B. Origins of breast cancer subtypes and therapeutic implications [ J ]. Nature Clin Pratt Oncol ,2007, 4:516 - 525.
-
3Lindvall C, Bu W, Williams B O, Li Y. Wnt signaling stem cells, and the cellular origin of breast cancer[ J]. Stem Cell Rev,2007, 3:157 -168.
-
4Brennan K R, Brown A M C. Wnt proteins in mammary development and cancer[J]. J Mammary Gland Biol Neoplasis, 2004,9: 119 -131.
-
5Farnie G,Clarke R B. Mammary stem cells and breast cancer-Role of Notch signaling[J]. Stem Cell Rev ,2007, 3 : 169 - 175.
-
6Wu F, Stutzman A, Mo Y Y. Notch Signaling and its role in breast cancer[ J]. Front Biasci,2007, 12 : 4370 -4383.
-
7Liu S, Dontu G, Mantle I D, et al. Hedgehog signaling and Bmi- 1 regulate self-renewal of normal and malignant human stem cells [ J ]. Cancer Res ,2006, 66 : 6063 - 6071.
-
8Lewis M T. Hedgehog signaling in mouse mammary gland development and neoplasia [J].J Mammary Gland Biology Neoplasia,2001, 6:53 -66.
-
9Shipitsin M, Campbell L L, Argani P,et al. Molecular definition of breast tumor heterogeneity[ J]. Cancer Cell ,2007, 11:259 - 273.
-
10Stingl J, Caldas C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis [ J ]. Nature Review Cancer, 2007, 7:791 - 799.
共引文献15
-
1吕新全,索振河,马长路,赵阿红,宋一民,李惠翔.干细胞样细胞在乳腺良恶性病变中的数量与分布[J].临床与实验病理学杂志,2008,24(4):428-431. 被引量:1
-
2赵武干,卢朝辉,陈杰.肿瘤干细胞及其研究[J].临床与实验病理学杂志,2010,26(4):481-483. 被引量:2
-
3张众,李连宏,王华新,谢丰培.癌肉瘤的上皮-间叶转变[J].临床与实验病理学杂志,2011,27(1):79-82. 被引量:9
-
4许立生,王水,黄中晶,沈恩超,钱超.CD44^+/CD24^(-/low)/ABCG2^-乳腺癌干细胞与临床治疗及预后的关系[J].实用医学杂志,2011,27(21):3877-3879. 被引量:5
-
5付明杰,王燕霞,王华新,白艳,张众,宋桂荣.乳腺浸润性癌组织p27和Skp2及E-cad表达生物学意义的研究[J].中华肿瘤防治杂志,2011,18(24):1920-1923. 被引量:4
-
6王翠翠,张巍,刘春霞,齐妍,李洪安,蒋金芳,李锋.滑膜肉瘤中E-、N-cadherin和β-catenin的表达及意义[J].临床与实验病理学杂志,2012,28(8):874-879. 被引量:6
-
7张众,李连宏,谢丰培.乳腺干细胞的识别、再生、分化及其调控[J].分子诊断与治疗杂志,2013,5(1):49-54. 被引量:2
-
8罗伟仁,姚开泰.间质标志物巢蛋白在鼻咽癌中的表达及其临床意义[J].临床与实验病理学杂志,2013,29(4):389-392. 被引量:1
-
9李连宏,Xiao Gary Guishan,张众,谢丰培.乳腺干细胞研究及其再生医学[J].临床与实验病理学杂志,2013,29(9):933-937. 被引量:2
-
10曾令瑞,韩玉贞,马英路,李文星.乳腺原发癌和相应淋巴结转移癌干细胞Wnt、Notch信号通路相关分子的比较[J].临床与实验病理学杂志,2014,30(9):963-966. 被引量:3
同被引文献49
-
1马涛,张君莹,吴建中,唐金海.miR-342-3p对三阴性乳腺癌化疗敏感性的影响[J].中南大学学报(医学版),2014,39(5):488-495. 被引量:8
-
2王宏志,喻春皓,高钧,赵广荣.HPLC分析比较炮制和提取方法对黄芩活性成分的影响[J].中国中药杂志,2007,32(16):1637-1640. 被引量:26
-
3Friel A M, Corcoran C, Crown J, 0;Driscoll L. Relevance of cir-culating tumor cells, extracellular nucleic acids and exosome inbreast cancer[J]. Breast Cancer Res Treat,2010,123(3) :613 -25.
-
4Tsang J C,Lo Y M. Circulating nucleic acids in plasma/serum[J]. Pathology, 2007,39(2) : 197-207.
-
5Chan A K, Chiu R W, Lo Y M. Cell-free nucleic acids in plas-ma ,serum and urine: a new tool in molecular diagnosis[ J]. AnnClin Biochem, 2003,40(pt2) :122 -30.
-
6Mostert B, Sieuwerts A M, Martens J W, Sleijfer S. Diagnosticapplications of cell-free and circulating tumor cell-associated miR-NAs in cancer patients[ J]. Expert Rev Mol Diagn,2011,11(3):259-75.
-
7Farazi T A, Spitzer J L, Monozov P, et al. miRNAs in humancancer[J]. J Pathol, 2011,223 : 102 - 15.
-
8Zhu W, Qin W, Atasoy U, Sauter E R. Circulating microRNAs inbreast cancer and healthy subjects[ J]. BMC Res Nots, 2009,2 :89.
-
9Roth C, Rack B, Muller V, et al. Circulating microRNAs asblood-based markers for patients with primary and Metastatic breastcancer [ J]. Breast Cancer Res, 2010,12(6) :R90.
-
10Asaga S, Kuo C, Nguyen T, et al. Direct serum assay for microR-IVA-21 concentrations in early and advanced breast cancer [ J].Clin Chem, 2011,57(1) :84-91.
引证文献5
-
1付明杰,李连宏,谢丰培,张众.乳腺癌相关的循环microRNA[J].临床与实验病理学杂志,2012,28(11):1254-1256.
-
2朴丽花,蔡英兰,张默函,姜京植,金政,许祖德.人参皂甙经PI3K/AKT通路诱导乳腺癌细胞凋亡[J].临床与实验病理学杂志,2013,29(9):946-949. 被引量:8
-
3朴丽花,蔡英兰,张默函,姜京植,金政,许祖德.人参皂苷Rh_2与PI3K/AKT信号通路抑制剂LY294002对乳腺癌细胞转移和侵袭的影响[J].中国药房,2013,24(43):4050-4052. 被引量:9
-
4肖玉洁,王婷,毛丹,陈州华,李阳,黄立中,无.黄芩苷通过影响miRNA的表达抑制乳腺癌细胞的侵袭转移[J].中药药理与临床,2017,33(2):41-44. 被引量:7
-
5郭晨明,李慧芳,欧提库尔·艾尼,罗志文,热艳娜·莫合塔尔,地力木拉提·艾斯木吐拉.miR-10b对三阴性乳腺癌化疗致敏性的作用研究[J].医学理论与实践,2021,34(20):3506-3509.
二级引证文献23
-
1鲍建勋,王号飞,黄云娟.人参皂苷Rg3联合奥沙利铂和索拉非尼对肝癌细胞凋亡的影响[J].中国生化药物杂志,2014,34(1):41-42. 被引量:8
-
2陈璐,张娟,栾丽平.黄芩苷通过增强自噬介导顺铂对宫颈癌C-33A/cis细胞敏感性的影响[J].中药药理与临床,2018,34(5):44-47. 被引量:10
-
3马晔琳,陈良良.疏肝健脾养阴方联合内分泌治疗激素依赖型乳腺癌的临床研究[J].中国医药导报,2014,11(22):94-98. 被引量:5
-
4张立.人参皂苷Rg3诱导乳腺癌MCF7Adr细胞凋亡的作用及其可能的分子机制[J].医学综述,2015,21(18):3391-3393. 被引量:4
-
5刘鲲,刘娜,刘苾川,吴秀青,丁艳.人参抗肿瘤药理研究[J].光明中医,2016,31(1):140-143. 被引量:13
-
6周运生,王凤泽.蛋白激酶B抑制剂CCT128930对人骨肉瘤U2-OS细胞凋亡与自噬的影响[J].中国药房,2016,27(13):1767-1770. 被引量:1
-
7司建功,田长恩.人参皂苷Rh2抗肿瘤机制的研究进展[J].时珍国医国药,2016,27(5):1190-1192. 被引量:10
-
8吴聪冲,陆一丹,吴青青,马芳笑,毛丹漪,刘晓谷.中药对乳腺癌MCF-7细胞的作用及机制研究进展[J].浙江中医药大学学报,2017,41(5):437-440. 被引量:4
-
9宋艳玲,韩鹏敏,杜新春,刘晓娟.抑制PI3K信号通路的抗肿瘤天然药物研究进展[J].现代药物与临床,2017,32(6):1156-1160. 被引量:6
-
10管连城,李文,陈伟,王焕珍,高洁,柴艺汇,秦忠,陈云志.人参与维生素D轴的潜在相关性研究[J].中华中医药学刊,2017,35(8):2078-2080. 被引量:11
-
1赵洪春,王延飞,郑体花,车娟,曹瑞娟,王霞.骨桥蛋白与喉鳞状细胞癌侵袭转移的相关研究[J].临床耳鼻咽喉头颈外科杂志,2015,29(17):1530-1533. 被引量:4
-
2汤艳.整合素αv、MMP-2、VEGF表达与卵巢上皮性癌侵袭转移的关系[J].中国现代医生,2012,50(29):49-51.
-
3尤嘉琮,周清华.肺癌侵袭转移相关microRNAs的研究进展[J].中国肺癌杂志,2010,13(3):265-269. 被引量:9
-
4姚旻.细胞粘附分子与癌侵袭转移研究进展[J].实用肿瘤杂志,1997,12(1):45-48.
-
5刘剑仑.nm23基因表达与乳腺癌侵袭转移的研究进展[J].肿瘤研究与临床,1999,11(5):350-352.
-
6侯莹,杨庆伟,刘延庆.基质金属蛋白酶2表达与胃癌侵袭及转移的关系[J].国际内科学杂志,2009,36(10):580-583.
-
7潘群雄,庄建良,苏子剑,许荣誉,王聪仁.CD24与原发性肝细胞癌侵袭转移的关系[J].国际肿瘤学杂志,2008,35(2):159-160.
-
8王晓燕,张艳开,任国春.MMP-2和MMP-9表达与卵巢上皮性癌侵袭转移的关系[J].中国肿瘤临床与康复,2004,11(5):406-408. 被引量:2
-
9张君薇,张毅,穆长征.MMP-2、MMP-9和VEGF与乳腺癌侵袭转移关系的研究[J].中国医师杂志,2010,12(11):1490-1493. 被引量:12
-
10钟安,杨为民,叶章群.MMP2及MMP9在膀胱移行细胞癌尿液中的表达及与侵袭转移关系的研究[J].临床外科杂志,2006,14(10):655-657. 被引量:1